( 9228 results )

IBBI: Penalizes IP for outsourcing his primary duty to verify claims received during CIRP

  • Citation Number : LSI-1154-IBBI-2021(NDEL)

NCLAT: Rejects GST Department’s belated claims filed after bid approval by CoC

  • Citation Number : LSI-1153-NCLAT-2021(NDEL)

NCLT: Terminates “right to use” Corporate Debtor’s trademark "CONCEPT Education" for Resolution Plan implementation

  • Citation Number : LSI-184-NCLT-2022(GAU)

HC: Can’t prosecute Director for cheque-dishonour, if company not arrayed as ‘accused’

  • Citation Number : LSI-183-HC-2022(CHA)

NCLT: Initiates insolvency process against realtor Supertech for Rs. 431 Cr. default

  • Citation Number : LSI-182-NCLT-2022(NDEL)

HC: Refuses to transfer winding up proceedings to NCLT, given “irreversible steps” taken

  • Citation Number : LSI-180-HC-2022(ALLD)

SC: SAT’s fact based findings cannot give rise to ‘question of law’; Rejects SEBI’s appeal

  • Citation Number : LSI-178-SC-2022(NDEL)

NCLAT: Decree Holder qualifies as ‘creditor’, eligible to initiate CIRP against Corporate Debtor

  • Citation Number : LSI-174-NCLAT-2022(CHE)

HC: Accused foreign national with no Indian roots, a ‘flight-risk’; Denies bail in PMLA case

  • Citation Number : LSI-173-HC-2022(DEL)

NCLAT: Claims can’t be ‘foisted’ upon Corporate Debtor’s purchaser post sale as ‘going concern’

  • Citation Number : LSI-171-NCLAT-2022(NDEL)

SC: Dismisses accused Directors’ appeal against HC order denying bail in PMLA case

  • Citation Number : LSI-169-SC-2022(NDEL)

NCLT: Directs Successful Resolution Applicant to not entertain Tax Commissioner’s claim post plan approval

  • Citation Number : LSI-1151-NCLT-2021(GAU)

NCLAT: Upholds NCLT order determining IRP’s fee, given full consideration of his claim

  • Citation Number : LSI-1150-NCLAT-2021(NDEL)

NCLAT: Rejects Financial Creditor’s plea challenging claim reduction by Liquidator, cites ‘exorbitant’ interest-rate

  • Citation Number : LSI-168-NCLAT-2022(NDEL)

NCLT: Mere holding of shares no ground to implead all shareholders in oppression-mismanagement litigation

  • Citation Number : LSI-166-NCLT-2022(KOC)

SAT: Upholds SEBI order restraining stockbroker from market, for insider trading in Aurobindo Pharma’s shares

  • Citation Number : LSI-164-SAT-2022(MUM)